Your cart is empty.
“Because our surveillance program relies on a network of regional laboratories, the standardized protocol, made possible by automation, is very important to maintain the consistent quality of results. The Tecan workstation achieves reliable and consistent yields of RNA, giving assurance of quality for our laboratory data and the surveillance system overall, and it is now a critically important device for the work we do,” Dr Cheon concluded.
To find out more on Tecan’s Freedom EVO workstations, visit www.tecan.com/freedomevo
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).
Tecan Group Ltd